Source: Annual Congress 2011 - COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Salman Sever, I. Conkbayir, M. Yuce Ege, S. Akcali, H. Firat, T. Kaplan, S. Ardic (Ankara, Turkey). The subclinical atherosclerosis and its association to clinical features of stable COPD. Eur Respir J 2011; 38: Suppl. 55, 546

Member's Comments

No comment yet.

Related content which might interest you: Structural and biochemical characteristics of subclinical atherosclerosis in COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 A new paradigm for classification of disease severity and progression of COPD Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 The relationship between comorbidities and systemic inflammation in patients with COPD Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018